Absorbable gelatin: Drug information

U.S. BRAND NAMES — Gelfilm®; Gelfoam®
PHARMACOLOGIC CATEGORY Hemostatic Agent
DOSING: ADULTS — Hemostasis: Local: Apply packs or sponges dry or saturated with sodium chloride. When applied dry, hold in place with moderate pressure. When applied wet, squeeze to remove air bubbles. The powder is applied as a paste prepared by adding approximately 4 mL of sterile saline solution to the powder.
DOSING: PEDIATRIC — Refer to adult dosing.
DOSING: ELDERLY — Refer to adult dosing.
DOSAGE FORMS — Excipient information presented when available (limited, particularly for generics); consult specific product labeling.
Film, ophthalmic (Gelfilm®): 25 mm x 50 mm (6s)
Film, topical (Gelfilm®): 100 mm x 125 mm (1s)
Powder, topical (Gelfoam®): 1 g
Sponge, dental (Gelfoam®): Size 4 (12s)
Sponge, topical (Gelfoam®): Size 50 (4s) Size 100 (6s) Size 200 (6s) Size 2 cm (1s) Size 6 cm (6s) Size 12-7 mm (12s)
DOSAGE FORMS: CONCISE Film, ophthalmic: Gelfilm®: 25 mm x 50 mm (6s)
Film, topical: Gelfilm®: 100 mm x 125 mm (1s)
Powder, topical: Gelfoam®: 1 g
Sponge, dental: Gelfoam®: Size 4 (12s)
Sponge, topical: Gelfoam®: Size 50 (4s) Size 100 (6s) Size 200 (6s) Size 2 cm (1s) Size 6 cm (6s) Size 12-7 mm (12s)
GENERIC EQUIVALENT AVAILABLE — No
USE — Adjunct to provide hemostasis in surgery; open prostatic surgery
ADVERSE REACTIONS SIGNIFICANT — 1% to 10%: Local: Infection and abscess formation
CONTRAINDICATIONS — Should not be used in closure of skin incisions since they may interfere with the healing of skin edges
WARNINGS / PRECAUTIONS — Do not sterilize by heat; do not use in the presence of infection
DRUG INTERACTIONS — No data reported
PREGNANCY RISK FACTOR — No (show table) data reported